Amarin Corporation plc News
Latest updates and market news for AMRN
3 news
Mar 1 - Mar 7, 2026
Page 1
Motley Fool
Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now
➖
AI Sentiment
Neutral
4/10
GlobeNewswire
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology
📈
AI Sentiment
Highly Positive
9/10
Share this news page